99m Tc-Sestamibi Thyroid Scintigraphy in Amiodarone-Induced Thyrotoxicosis : Functional Imaging-Histopathologic Correlation

Clin Nucl Med. 2022 Sep 1;47(9):e582-e584. doi: 10.1097/RLU.0000000000004332. Epub 2022 Jul 15.

Abstract

99m Tc-sestamibi thyroid scintigraphy (STS) can aid in differentiating between types 1 and 2 amiodarone-induced thyrotoxicosis (AIT). We present a consecutive case series of 4 men (aged 56-75 years) in whom both 99m Tc-STS and thyroid histology were consistent with a diagnosis of type 2 AIT, representing the first reported histopathologic correlation for this diagnostic test. Median amiodarone treatment duration was 26 months (range, 10-39 months), and amiodarone was discontinued a median of 3 months preoperatively (range, 2-4 months) in all 4 cases. 99m Tc-STS is a promising functional imaging modality, which has the potential to aid clinicians in the diagnostic workup and treatment of AIT.

MeSH terms

  • Amiodarone* / adverse effects
  • Anti-Arrhythmia Agents / adverse effects
  • Humans
  • Hyperthyroidism*
  • Male
  • Radionuclide Imaging
  • Technetium Tc 99m Sestamibi
  • Thyrotoxicosis* / chemically induced
  • Thyrotoxicosis* / diagnostic imaging

Substances

  • Anti-Arrhythmia Agents
  • Technetium Tc 99m Sestamibi
  • Amiodarone